Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT05403723
Title Adaptive SBRT Plus Chemoimmunotherapy for ES-SCLC
Recruitment Not yet recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Taofeek Owonikoko
Indications

lung small cell carcinoma

Therapies

Cisplatin + Durvalumab + Etoposide

Carboplatin + Durvalumab + Etoposide

Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.